Management of aggressive fibromatosis: can we unravel the maze of treatment options?
Sleijfer
Stefan
S
D019317:Evidence-Based Medicine / Q000379:methods; D018222:Desmoid Tumors / Q000378:metabolism / Q000628:therapy*; D006801:Humans; D009363:Neoplasm Proteins / Q000378:metabolism; D011379:Prognosis; D051176:beta Catenin / Q000378:metabolism
C495270:CTNNB1 protein, human; D009363:Neoplasm Proteins; D051176:beta Catenin